314 results
Page 2 of 16
8-K
EX-99.1
tvkuu5x8y7gks7
23 Oct 23
Other Events
4:23pm
8-K
EX-10.1
pbs0htz 62tv
12 Sep 23
Departure of Directors or Certain Officers
4:11pm
8-K/A
EX-99.1
7s1spx69 uok
14 Aug 23
Aspira Women’s Health® Reports Second Quarter 2023 Financial Results
5:27pm
8-K
EX-10.1
hkrj5ioaj6jb8q 8r
24 Jul 23
Entry into a Material Definitive Agreement
5:05pm
424B5
p5nctxze98 rle
24 Jul 23
Prospectus supplement for primary offering
5:01pm
8-K
EX-10.1
rx3qkwahkhfg822u3ag2
16 May 23
Departure of Directors or Certain Officers
4:41pm
8-K
EX-99.1
ukjq42b7u f37tr
11 May 23
First Quarter total product revenue of $2.3 million, an increase of 26% year-over-year
4:33pm
8-K
EX-99.1
tf4hg30n
28 Apr 23
Preliminary first quarter 2023 volume was 6,259 tests, an increase of 29% compared to last year, the highest volume quarter in the company’s history
5:30pm
8-K
EX-10.1
zvn38n
30 Nov 22
Departure of Directors or Certain Officers
4:38pm
8-K
EX-99.1
wubp2ozzo9vu6cr5rmpx
10 Nov 22
Aspira Women’s Health Reports Third Quarter 2022 Financial Results
8:24am